Law360, New York (January 01, 2003) -- A judge has stayed a securities fraud class action accusing Pfizer Inc. of misrepresenting clinical studies of arthritis painkiller Celebrex because the U.S. Supreme Court has decided to take on a similar case.
In an order filed Wednesday, Judge Anne E. Thompson of the U.S. District Court for the District of New Jersey stayed the case. She said Merck & Co. Inc. et...
